Fertility North is delighted to offer patients the latest in cutting edge infertility treatment and technology. ERA® is the latest new procedure we have added to our arsenal.
The Endometrial Receptivity Analysis (ERA®) test is designed to evaluate the timing of endometrial receptivity.
This diagnostic tool analyzes the expression of 236 genes related to the status of endometrial recptivity at a molecular level.
The ERA® test is used to evaluate the stage of an endometrium to determine whether it is receptive or non-receptive at the time of biopsy. In the case where the endometrium is non-receptive, the test enables us to find a personalised window of implantation for each patient. This gives us the time when the endometrial lining will be most receptive to an embryo transfer, improving the chances of success.
This test has been proven to be more sensitive than the classical method of endometrial dating.
The ERA® test has been proven to help patients who have experienced implantation failure while using good quality embryos.